Depression, Anxiety, and Quality of Life in Patients Treated with Single Infusion Tocilizumab for COVID-19: A Follow-up, Controlled Study

Background: The inflammatory state that characterizes COVID-19 may contribute to depression, anxiety, other morbidities, and mortality. Interleukin-6 blocker tocilizumab has been used as a treatment modality in COVID-19 as an anti-inflammatory agent. Tocilizumab has also been studied for its potenti...

Full description

Bibliographic Details
Published in:	Indian Journal of Psychological Medicine
Main Authors:	Rahul Chakravarty, Gaurav Jyani, Samita Paul, Ritin Mohindra, Manoj Goyal, Vikas Suri, Ashish Bhalla, Shubh Mohan Singh
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-01-01
Online Access:	https://doi.org/10.1177/02537176221140557

Similar Items

Prevention of surgical site infections: Where do we stand today?
by: Vikas Suri, et al.
Published: (2024-06-01)

Clinical spectrum and outcomes of adult varicella (chickenpox) in India
by: Ritin Mohindra, et al.
Published: (2025-07-01)

Safety, immunogenicity, and breakthrough infections during 1-year follow-up after COVISHIELD™ vaccination among healthcare workers in a teaching institute in North India: A prospective longitudinal study
by: Madhu Gupta, et al.
Published: (2025-02-01)

Superspreaders: A Lurking Danger in the Community
by: Ritin Mohindra, et al.
Published: (2021-01-01)

Up the Duff With Non-Hodgkin’s Lymphoma: The Traumas and the Dilemmas
by: Sheeba Marwah, et al.
Published: (2017-02-01)

Role of aromatase inhibitors in managing hypogonadism in adult males related to obesity and aging: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2022-01-01)

Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
by: Amee D Pandya, et al.
Published: (2019-01-01)

Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trial
by: Ramya Rathod, et al.
Published: (2022-07-01)

Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
by: Chayma Ladhari, et al.
Published: (2020-02-01)

An Experience with Manual Ventilation in Respiratory Paralysis Due to Indian Common Krait (Bungarus Caeruleus) Bite
by: Ashish Bhalla, et al.
Published: (2014-06-01)

An Unusual Case of Pneumocystis jirovecii Cystic Pneumonia
by: Harpreet Singh, et al.
Published: (2024-06-01)

Tocilizumab (Actemra)
by: Martin Sheppard, et al.
Published: (2017-09-01)

An Unusual Case of Post-partum Native Tricuspid Valve Infective Endocarditis
by: Krishna Divyashree, et al.
Published: (2023-09-01)

Quality of life and financial implications of depression in India
by: Neha Purohit, et al.
Published: (2025-07-01)

Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
by: Deep Dutta, et al.
Published: (2023-01-01)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
by: C.S. Kow, et al.
Published: (2021-01-01)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
by: C.S. Kow, et al.
Published: (2021-01-01)

Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
by: Shipra Gupta, et al.
Published: (2022-08-01)

Do people with different sociodemographic backgrounds value their health differently? Evaluating the role of positional objectivity
by: Gaurav Jyani, et al.
Published: (2023-12-01)

Framework for responsive financing of district hospitals of India
by: Shankar Prinja, et al.
Published: (2024-10-01)

Myositis and rhabdomyolysis in scrub typhus infection: A case report
by: Tukaram Bolla, et al.
Published: (2023-01-01)

Depression and Anxiety among Tuberculosis Patients: A Systematic Review and Meta-analysis
by: Vikas Panibatla, et al.
Published: (2024-11-01)

Tocilizumab Reduces Depression Risk in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis
by: Baghdadi LR
Published: (2024-10-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
by: Nadia K. Rafiq, et al.
Published: (2018-01-01)

Dysthyroid optic neuropathy treated with tocilizumab
by: Yuerong Yan, et al.
Published: (2025-02-01)

Tocilizumab-Induced Erythema Annulare Centrifugum
by: Ana Luísa João, et al.
Published: (2022-10-01)

A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab
by: Chance H. Bloomer, et al.
Published: (2022-01-01)

Epidemic of Depression and Anxiety in child and adolescent population during COVID-19 pandemic: A systematic review and meta analysis of the prevalence of depression and anxiety
by: Gaurav Maggu, et al.
Published: (2023-03-01)

Supplementation of critical micro-nutrients in peri‑parturient dairy buffaloes improves lactation performance
by: Vikas Jyani, et al.
Published: (2024-06-01)

Anxiety and depression among healthcare workers during the COVID-19 pandemic: a systematic umbrella review of the global evidence
by: Elizabeth J Halcomb, et al.
Published: (2021-09-01)

Role of novel glucagon-like peptide-1 receptor analogue polyethylene glycol loxenatide in type 2 diabetes: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2023-01-01)

Children of parents with depression or anxiety: Long‐term follow‐up, causality and resilience
by: Henrik Larsson
Published: (2023-12-01)

Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritis
by: Sebastian H Unizony, et al.
Published: (2023-05-01)

Anxiety, depression, and perceived stress among loco pilots of Indian Railways
by: Bharat Singh Shekhawat, et al.
Published: (2024-08-01)

Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors
by: V. I. Petrov, et al.
Published: (2022-04-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

Use of tocilizumab for rheumatoid arthritis: new evidence
by: Evgeny Lvovich Nasonov
Published: (2011-12-01)

A spectacular effect of tocilizumab in Takayasu arteritis
by: Fatma Saïd, et al.
Published: (2024-11-01)